INDUCTION OF ARTHRITIS WITH MONOCLONAL-ANTIBODIES TO COLLAGEN

被引:0
|
作者
TERATO, K
HASTY, KA
REIFE, RA
CREMER, MA
KANG, AH
STUART, JM
机构
[1] VET ADM MED CTR,RES SERV 151,1030 JEFFERSON AVE,MEMPHIS,TN 38104
[2] UNIV TENNESSEE CTR HLTH SCI,DEPT MED,MEMPHIS,TN 38163
[3] UNIV TENNESSEE CTR HLTH SCI,DEPT ANAT,MEMPHIS,TN 38163
[4] UNIV TENNESSEE CTR HLTH SCI,DEPT BIOCHEM,MEMPHIS,TN 38163
来源
JOURNAL OF IMMUNOLOGY | 1992年 / 148卷 / 07期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
mAb were developed from DBA/1 mice immunized with chick type II collagen. A total of 69 IgG antibodies was isolated and characterized. The majority (36%) reacted with a CNBr-derived peptide CB11 previously identified as containing a major immunogenic and arthritogenic epitope(s). Seven of the antibodies reactive with CB11 crossreacted strongly with mouse type II collagen. These were administered to DBA/1 mice in an attempt to induce arthritis. Individual antibodies were able to induce mild lesions consisting of minimal synovial proliferation but not overt arthritis. However, a combination of antibodies induced severe arthritis with marked destruction of articular cartilage. The minimal effective combination consisted of three antibodies. Arthritis developed within 48 to 72 h after injection of the antibodies and persisted for the duration of the observation period of 3 wk. Antibody levels were measured at intervals and persisted for the 3 wk observation period although at diminishing levels. Competitive binding assays demonstrated that each of the effective antibodies bound independently suggesting that some spatial or quantitative relationship was important possibly related to their ability to activate complement.
引用
收藏
页码:2103 / 2108
页数:6
相关论文
共 50 条
  • [1] MONOCLONAL-ANTIBODIES AND ARTHRITIS
    BILLINGHAM, MEJ
    HICKS, C
    CARNEY, S
    [J]. AGENTS AND ACTIONS, 1990, 29 (1-2): : 77 - 87
  • [2] SUPPRESSION OF TYPE-II COLLAGEN INDUCED ARTHRITIS BY MONOCLONAL-ANTIBODIES
    KOBAYASHI, S
    TERATO, K
    HARADA, Y
    MORIYA, H
    TANIGUCHI, M
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (01): : 48 - 54
  • [3] MONOCLONAL-ANTIBODIES AND RHEUMATOID-ARTHRITIS
    WENDLING, D
    [J]. REVUE DE MEDECINE INTERNE, 1993, 14 (07): : 705 - 714
  • [4] MONOCLONAL-ANTIBODIES FOR THE INDUCTION OF TRANSPLANTATION TOLERANCE
    WALDMANN, H
    COBBOLD, S
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (05) : 753 - 758
  • [5] INDUCTION OF ANTIGENIC MODULATION BY MONOCLONAL-ANTIBODIES
    ESTABROOK, A
    BERGER, CL
    LOGERFO, P
    EDELSON, RL
    [J]. CLINICAL RESEARCH, 1982, 30 (02): : A261 - A261
  • [6] MONOCLONAL-ANTIBODIES TO TYPE-X COLLAGEN
    SUMMERS, TA
    BALIAN, G
    [J]. FEDERATION PROCEEDINGS, 1986, 45 (06) : 1683 - 1683
  • [7] MONOCLONAL-ANTIBODIES IN THE TREATMENT OF RHEUMATOID-ARTHRITIS
    DELAFUENTE, JC
    RESMANTARGOFF, BH
    [J]. ANNALS OF PHARMACOTHERAPY, 1994, 28 (05) : 650 - 654
  • [8] MONOCLONAL-ANTIBODIES IN THE TREATMENT OF RHEUMATOID-ARTHRITIS
    WENDLING, D
    RACADOT, E
    [J]. PRESSE MEDICALE, 1992, 21 (36): : 1725 - 1729
  • [9] MONOCLONAL-ANTIBODIES FOR IMMUNOINTERVENTION IN RHEUMATOID-ARTHRITIS
    HORNEFF, G
    BURMESTER, GR
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 1995, 54 (02): : 96 - 104
  • [10] INDUCTION OF IMMUNOGENICITY OF MONOCLONAL-ANTIBODIES BY CONJUGATION WITH DRUGS
    JOHNSON, DA
    BARTON, RL
    FIX, DV
    SCOTT, WL
    GUTOWSKI, MC
    [J]. CANCER RESEARCH, 1991, 51 (20) : 5774 - 5776